About RenPharm
RenPharm is a company based in Newton (United States) founded in 2016 was acquired by LTS Lohmann in October 2025. The company has 462 employees as of December 31, 2021. RenPharm operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Newton, United States
- Employees 462 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
462
as on Dec 31, 2021
-
Acquired by
LTS Lohmann
(Oct 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of RenPharm
Unlock access to complete
Funding Insights of RenPharm
Detailed funding history for RenPharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in RenPharm
RenPharm has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LTS Lohmann.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug delivery systems targeting multiple disease indications are developed.
|
Locked | Locked | Locked |
Investor details for RenPharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RenPharm
Investment portfolio details for RenPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RenPharm
Detailed financials for RenPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renpharm Comparisons
Peer comparison for RenPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RenPharm
RenPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of RenPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renpharm
Complete news archive for RenPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RenPharm
RenPharm was founded in 2016.
RenPharm is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
As of Dec 31, 2021, the latest employee count at RenPharm is 462.
Founded in 2016 and based in Newton, United States, Renaissance operates in the pharmaceutical sector, focusing on contract development and manufacturing. Capabilities include production of injectable solutions, suspensions, ointments, gels, patches, and formulations for nasal, ophthalmic, and otic uses. Compliance is maintained with FDA, EMEA, and DEA standards across three cGMP facilities totaling 310,000 square feet.
RenPharm's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
RenPharm has 1 investor. Key investors include LTS Lohmann.